Comparison of diagnostic methods to detect Histoplasma capsulatum in serum and blood samples from AIDS patients

Imagem de Miniatura
Arquivos
art_DANTAS_Comparison_of_diagnostic_methods_to_detect_Histoplasma_capsulatum_2018.PDF (4.67 MB)
Citações na Scopus
23
Tipo de produção
article
Data de publicação
2018
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Autores
SILVA, Marcos Vinicius da
VICENTINI, Adriana Pardini
Citação
PLOS ONE, v.13, n.1, article ID e0190408, 12p, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Although early and rapid detection of histoplasmosis is essential to prevent morbidity and mortality, few diagnostic tools are available in resource-limited areas, especially where it is endemic and HIV/AIDS is also epidemic. Thus, we compared conventional and molecular methods to detect Histoplasma capsulatum in sera and blood from HIV/AIDS patients. Methodology We collected a total of 40 samples from control volunteers and patients suspected of histoplasmosis, some of whom were also infected with other pathogens. Samples were then analyzed by mycological, serological, and molecular methods, and stratified as histoplasmostic with (group I) or without AIDS (group II), uninfected (group III), and infected with HIV and other pathogens only (group IV). All patients were receiving treatment for histoplasmosis and other infections at the time of sample collection. Results Comparison of conventional methods with nested PCR using primers against H. capsulatum 18S rRNA (HC18S), 5.8S rRNA ITS (HC5.8S-ITS), and a 100 kDa protein (HC100) revealed that sensitivity against sera was highest for PCR with HC5.8S-ITS, followed by immunoblotting, double immunodiffusion, PCR with HC18S, and PCR with HC100. Specificity was equally high for double immunodiffusion, immunoblotting and PCR with HC100, followed for PCR with HC18S and HC5.8-ITS. Against blood, sensitivity was highest for PCR with HC5.8S-ITS, followed by PCR with HC18S, Giemsa staining, and PCR with HC100.Specificity was highest for Giemsa staining and PCR with HC100, followed by PCR with HC18S and HC5.8S-ITS. PCR was less efficient in patients with immunodeficiency due to HIV/AIDS and/or related diseases. Conclusion Molecular techniques may detect histoplasmosis even in cases with negative serology and mycology, potentially enabling early diagnosis.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/24950
Referências
  1. Elias NA, 2012, MYCOPATHOLOGIA, V174, P451, DOI 10.1007/s11046-012-9567-2
  2. Almeida MD, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1427-0
  3. Bahr Nathan C, 2015, Curr Trop Med Rep, V2, P70
  4. Bialek R, 2002, AM J CLIN PATHOL, V117, P597
  5. Bialek R, 2002, J CLIN MICROBIOL, V40, P1644, DOI 10.1128/JCM.40.5.1644-1647.2002
  6. Bracca A, 2003, J CLIN MICROBIOL, V41, P1753, DOI 10.1128/JCM.41.4.1753-1755.2003
  7. Buitrago MJ, 2006, EUR J CLIN MICROBIOL, V25, P665, DOI 10.1007/s10096-006-0207-y
  8. Caceres DH, 2015, AM J TROP MED HYG, V93, P662, DOI 10.4269/ajtmh.15-0108
  9. COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
  10. Dantas KC, 2013, AN BRAS DERMATOL, V88, P141, DOI 10.1590/S0365-05962013000100025
  11. de Hoog G.S., 2000, ATLAS CLIN FUNGI
  12. DISALVO AF, 1980, J CLIN MICROBIOL, V11, P238
  13. ERCOLANI L, 1988, J BIOL CHEM, V263, P15335
  14. Falci DR, 2017, BRAZ J INFECT DIS, V21, P7, DOI 10.1016/j.bjid.2016.09.012
  15. Fletcher RH, 1996, EPIDEMIOLOGIA CLIN E, P52
  16. Freitas RS, 2009, J VENOM ANIM TOXINS, V15, P278, DOI 10.1590/S1678-91992009000200010
  17. Fujita SI, 2001, J CLIN MICROBIOL, V39, P3617, DOI 10.1128/JCM.39.10.3617-3622.2001
  18. Garbee DD, 2017, CRIT CARE NURS CLIN, V29, P67, DOI 10.1016/j.cnc.2016.09.011
  19. Frias-De-Leon M, 2017, FOLIA MICROBIOL, V62, P111, DOI 10.1007/s12223-016-0477-4
  20. Guimaraes AJ, 2006, BRAZ J MICROBIOL, V37, P1, DOI 10.1590/S1517-83822006000100001
  21. Kauffman CA, 2008, CURR OPIN INFECT DIS, V21, P421, DOI 10.1097/QCO.0b013e328306eb8d
  22. LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
  23. Martagon-Villamil J, 2003, J CLIN MICROBIOL, V41, P1295, DOI 10.1128/JCM.41.3.1295-1298.2003
  24. Nacher M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002319
  25. Negroni R, 2010, REV ARGENT MICROBIOL, V42, P254, DOI 10.1590/S0325-75412010000400003
  26. Brilhante RSN, 2010, ANTIMICROB AGENTS CH, V54, P3978, DOI 10.1128/AAC.00793-10
  27. Ohno H, 2013, J INFECT CHEMOTHER, V19, P999, DOI 10.1007/s10156-013-0548-2
  28. Ostrosky-Zeichner L, 2012, AM J MED, V125, pS14, DOI 10.1016/j.amjmed.2011.10.008
  29. Passos AN, 2014, BRAZ J MICROBIOL, V45, P1357, DOI 10.1590/S1517-83822014000400028
  30. Powers-Fletcher MV, 2016, INFECT DIS CLIN N AM, V30, P37, DOI 10.1016/j.idc.2015.10.005
  31. Prado M, 2009, MEM I OSWALDO CRUZ, V104, P513, DOI 10.1590/S0074-02762009000300019
  32. Prattes J, 2016, CURR FUNGAL INFECT R, V10, P43, DOI 10.1007/s12281-016-0254-5
  33. Rivasi F, 2001, APMIS, V109, P721, DOI 10.1034/j.1600-0463.2001.d01-138.x
  34. Sampaio ID, 2012, REV IBEROAM MICOL, V29, P34, DOI 10.1016/j.riam.2011.03.008
  35. Scheel CM, 2014, J CLIN MICROBIOL, V52, P483, DOI 10.1128/JCM.02739-13
  36. Toranzo AI, 2009, REV ARGENT MICROBIOL, V41, P20
  37. Wheat LJ, 2006, TRANSPL INFECT DIS, V8, P128, DOI 10.1111/j.1399-3062.2006.00165.x
  38. Wheat LJ, 2016, INFECT DIS CLIN N AM, V30, P207, DOI 10.1016/j.idc.2015.10.009
  39. White T. J., 1990, PCR PROTOCOLS GUIDE, V1990, P315, DOI 10.1139/B07-071
  40. ZANCOPEOLIVEIRA RM, 1994, CLIN DIAGN LAB IMMUN, V1, P197

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - LIM/05
Artigos e Materiais de Revistas Científicas - LIM/38
Artigos e Materiais de Revistas Científicas - LIM/53
Artigos e Materiais de Revistas Científicas - ODS/03